ROSSARI BIOTECH
|
ROSSARI BIOTECH Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 26.94 | 24.63 | 23.66 | 19.45 | 17.74 |
| CEPS(Rs) | 41.23 | 36.75 | 34.59 | 30.86 | 26.47 |
| DPS(Rs) | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 |
| Book NAV/Share(Rs) | 239.75 | 213.72 | 189.01 | 165.29 | 145.65 |
| Tax Rate(%) | 26.32 | 26.36 | 26.42 | 25.63 | 28.31 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 11.18 | 12.19 | 13.22 | 12.91 | 11.84 |
| EBIT Margin(%) | 9.60 | 9.74 | 10.71 | 10.02 | 10.00 |
| Pre Tax Margin(%) | 8.41 | 8.88 | 9.66 | 8.68 | 9.15 |
| PAT Margin (%) | 6.20 | 6.54 | 7.11 | 6.45 | 6.56 |
| Cash Profit Margin (%) | 9.49 | 9.76 | 10.39 | 10.24 | 9.78 |
| Performance Ratios | |||||
| ROA(%) | 6.16 | 6.80 | 7.70 | 7.18 | 9.48 |
| ROE(%) | 11.88 | 12.25 | 13.36 | 12.52 | 16.17 |
| ROCE(%) | 14.84 | 16.07 | 18.39 | 18.48 | 24.37 |
| Asset Turnover(x) | 0.99 | 1.04 | 1.08 | 1.11 | 1.45 |
| Sales/Fixed Asset(x) | 2.39 | 2.50 | 2.40 | 2.30 | 3.18 |
| Working Capital/Sales(x) | 5.39 | 4.13 | 4.39 | 4.47 | 4.73 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.42 | 0.40 | 0.42 | 0.44 | 0.31 |
| Receivable days | 78.24 | 78.74 | 77.31 | 72.29 | 55.00 |
| Inventory Days | 57.59 | 55.79 | 46.74 | 41.54 | 34.95 |
| Payable days | 66.69 | 64.36 | 56.45 | 57.21 | 52.27 |
| Valuation Parameters | |||||
| PER(x) | 14.04 | 24.52 | 28.51 | 30.61 | 51.49 |
| PCE(x) | 9.18 | 16.44 | 19.50 | 19.29 | 34.51 |
| Price/Book(x) | 1.58 | 2.83 | 3.57 | 3.60 | 6.27 |
| Yield(%) | 0.13 | 0.08 | 0.07 | 0.08 | 0.05 |
| EV/Net Sales(x) | 1.01 | 1.67 | 2.08 | 1.95 | 3.36 |
| EV/Core EBITDA(x) | 7.82 | 12.91 | 14.78 | 14.15 | 25.51 |
| EV/EBIT(x) | 10.43 | 17.12 | 19.30 | 19.42 | 33.48 |
| EV/CE(x) | 1.38 | 2.53 | 3.30 | 3.27 | 3.52 |
| M Cap / Sales | 0.87 | 1.61 | 2.04 | 1.98 | 3.39 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 15.19 | 13.64 | 10.55 | 11.66 | 109.06 |
| Core EBITDA Growth(%) | 14.56 | 4.62 | 12.56 | 16.92 | 47.78 |
| EBIT Growth(%) | 13.82 | 3.05 | 18.29 | 11.82 | 35.60 |
| PAT Growth(%) | 9.41 | 4.35 | 21.85 | 9.79 | 22.05 |
| EPS Growth(%) | 9.37 | 4.13 | 21.65 | 9.61 | 14.85 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.31 | 0.16 | 0.10 | 0.08 | 0.01 |
| Current Ratio(x) | 1.44 | 1.68 | 1.72 | 1.78 | 1.87 |
| Quick Ratio(x) | 1.04 | 1.20 | 1.23 | 1.39 | 1.35 |
| Interest Cover(x) | 8.10 | 11.40 | 10.17 | 7.46 | 11.77 |
| Total Debt/Mcap(x) | 0.19 | 0.06 | 0.03 | 0.02 | - |
Compare Financial Ratios of peers of ROSSARI BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ROSSARI BIOTECH | ₹2,901.3 Cr | -2% | -3.9% | -21.6% | Stock Analytics | |
| SOLAR INDUSTRIES INDIA | ₹168,695.0 Cr | 7.1% | 1.4% | 9.5% | Stock Analytics | |
| PIDILITE INDUSTRIES | ₹163,368.0 Cr | 0.6% | 10.4% | 5.2% | Stock Analytics | |
| SRF | ₹82,964.9 Cr | 2.5% | 1.9% | -11.2% | Stock Analytics | |
| GUJARAT FLUOROCHEMICALS | ₹43,636.8 Cr | 1.5% | 8.6% | 13.7% | Stock Analytics | |
| GODREJ INDUSTRIES | ₹40,773.6 Cr | 4.5% | 14.3% | -4.1% | Stock Analytics | |
ROSSARI BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ROSSARI BIOTECH | -2% |
-3.9% |
-21.6% |
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses
